Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 43 of the 53 references it cites were found in a registry or an index, and 6 are not checked yet; 2 of the 53 sources its claims cite were checked for support.

The Histamine-Associated Inflammatory Landscape of Endometriosis: Molecular Profiling of HDC, HRH1-HRH4, and Cytokines Across Lesion Subtypes

Open access

Abstract

Pain in endometriosis involves not only nociceptive but also neuropathic and neurogenic components, reflecting its complex nature. Histamine, a biogenic amine, has emerged as a critical mediator connecting inflammation and nerve sensitization. This study aimed to characterize histamine receptor (HRH1–HRH4) expression, localization, and related inflammatory mediators in peritoneal, deep infiltrating, and ovarian endometriosis. Gene expression datasets were analyzed, and immunofluorescence staining of endometriotic lesions was performed using immune and neuronal markers. Histamine and its metabolite methylhistamine were quantified in serum, peritoneal fluid, and urine samples. HDC expression was significantly elevated in all endometriotic lesions compared with controls (all p < 0.01), paralleling increased IL-6, COX-2, NGF, and NGFR levels (p < 0.0001). In contrast, HRH1–HRH4 transcript levels showed no significant differences between groups. Immunofluorescence demonstrated robust HRH1–HRH4 protein expression in epithelial, immune, and nerve fibers, with subtype-specific colocalization patterns. Serum histamine concentrations were significantly higher in endometriosis patients than controls (0.484 vs. 0.153 ng/mg protein; p = 0.0014), whereas peritoneal histamine and urinary methylhistamine showed no group differences. Overall, these findings highlight histamine signaling as a potentially important component of endometriosis pathophysiology and point toward new directions for mechanistic studies and therapeutic exploration.

Verified 2026-10-11 · 6 references not checked yet

Overview

CoChat Summary

## TL;DR

This study maps histamine-related biology across endometriosis subtypes and finds elevated HDC plus inflammatory mediators, along with histamine receptor protein expression in immune cells and nerve fibers within lesions. It also reports higher serum histamine in endometriosis, but no difference in peritoneal fluid histamine or urinary methylhistamine versus controls.

## Key findings

  • In GEO dataset analysis (330 patients with endometriosis, 62 controls), HDC expression was higher in peritoneum (9.40, 9.07–9.62), peritoneal endometriosis (8.71, 8.08–9.27), deep infiltrating endometriosis (9.38, 8.79–9.92), and ovarian endometriosis (8.33, 8.00–9.07) than in control tissue (7.01, 6.54–8.37) and patient endometrium (7.24, 6.77–7.51; all reported significant comparisons).
  • IL-6, COX2, NGF, and NGFR were also increased in multiple lesion subtypes; for example, COX2 was highest in deep infiltrating endometriosis (8.86, 8.12–9.76) versus controls (7.08, 6.81–7.38; p < 0.0001), and NGFR was elevated in patient peritoneum (7.48, 7.10–7.89), peritoneal endometriosis (7.24, 6.88–7.66), and deep infiltrating endometriosis (6.99, 6.65–7.48) versus controls and patient endometrium (all p < 0.0001).
  • Transcriptomic analysis found no statistically significant differences in HRH1–HRH4 mRNA across groups, but immunofluorescence detected all four receptors in lesions: in peritoneal endometriosis, receptor expression was higher than controls for HRH1 (5.17 vs 1.80; p = 0.01), HRH2 (22.48 vs 0.61; p < 0.0001), HRH3 (7.76 vs 2.85; p = 0.0045), and HRH4 (28.67 vs 2.16; p < 0.0001).
  • Histamine was found in a more systemic pattern: serum histamine was higher in endometriosis patients (0.484 ng/mg) than controls (0.153 ng/mg; p = 0.0014), while peritoneal fluid histamine did not differ (0.463 ng/mg vs 0.554 ng/mg; p = 0.1314) and urinary methylhistamine also did not differ (109.6 ± 38.94 μg/g creatinine vs 113.0 ± 45.55 μg/g creatinine; p = 0.9534).

## Methods

  • The study combined four analyses: re-analysis of the public GEO dataset GSE141549, immunofluorescence on lesion/control tissues, ELISA measurement of histamine in serum and peritoneal fluid, and HPLC measurement of urinary methylhistamine.
  • Tissue immunofluorescence used 30 endometriosis samples total (10 each of peritoneal, deep infiltrating, and ovarian endometriosis) and 15 location-matched controls; gene-expression analysis used 330 endometriosis patients and 62 controls.
  • Main analyses included Kruskal–Wallis/Dunn’s, Mann–Whitney U, and Spearman correlation tests; receptor localization was assessed with co-staining for CD45, PGP9.5, substance P, TH, and VIP.

## Limitations

  • The paper explicitly states that the sample size per lesion subtype was relatively small, receptor quantification was semi-quantitative, the study was cross-sectional, and it did not perform functional assays to test downstream signaling or receptor-specific pharmacologic responses.
  • The authors note that the public GEO dataset may be affected by batch effects or sample heterogeneity.
  • Evident from the text: some control groups were small, including n = 5 for each subtype-matched tissue control in the immunofluorescence work and n = 10 controls for peritoneal fluid, which may limit precision.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms27010212

Cites

43 of 53 references verified0 citation errors · 4 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Altered Expression Patterns of Histamine Receptors, HDC, and Inflammatory Genes in Endometriosis and Control Tissues. Gene expression levels of HRH1 (A), HRH2 (B), HRH3 (C), HRH4 (D), HDC (E), IL-6 (F), COX2 (G), VEGFA (H), NGF (I), and NGFR (J) across the following groups: Control (N = 38), Patient Endometrium (N = 98), Patient Peritoneum (N = 37), peritoneal endometriosis (pEM; N = 78), deep infiltrating endometriosis (DIE; N = 88), and ovarian endometriosis (Ovarian EM; N = 29). Statistical analysis was performed using the Kruskal–Wallis test. a vs. Control group; b vs. Patient Endometrium; c vs. Patient Peritoneum; d vs. pEM; e vs. DIE.
Figure 1 Altered Expression Patterns of Histamine Receptors, HDC, and Inflammatory Genes in Endometriosis and Control Tissues. Gene expression levels of HRH1 (A), HRH2 (B), HRH3 (C), HRH4 (D), HDC (E), IL-6 (F), COX2 (G), VEGFA (H), NGF (I), and NGFR (J) across the following groups: Control (N = 38), Patient Endometrium (N = 98), Patient Peritoneum (N = 37), peritoneal endometriosis (pEM; N = 78), deep infiltrating endometriosis (DIE; N = 88), and ovarian endometriosis (Ovarian EM; N = 29). Statistical analysis was performed using the Kruskal–Wallis test. a vs. Control group; b vs. Patient Endometrium; c vs. Patient Peritoneum; d vs. pEM; e vs. DIE.CC BY · PubMed Central
Figure 2 Influence of cycle phase and hormonal intake on mean gene expression of HDC (A) and HRH1 (B). Gene expression was compared across the following tissue groups: Control (N = 38), Patient Endometrium (N = 98), Patient Peritoneum (N = 37), peritoneal endometriosis (pEM; N = 78), deep infiltrating endometriosis (DIE; N = 88), and ovarian endometriosis (Ovarian EM; N = 29). Within each group, patients were categorized according to menstrual cycle phase (menstruation, proliferative, secretory) and hormonal medication at the time of sample collection. Statistical analysis was performed using the Kruskal–Wallis test. p < 0.05 (*), p < 0.001 (***), p < 0.0001 (****).
Figure 2 Influence of cycle phase and hormonal intake on mean gene expression of HDC (A) and HRH1 (B). Gene expression was compared across the following tissue groups: Control (N = 38), Patient Endometrium (N = 98), Patient Peritoneum (N = 37), peritoneal endometriosis (pEM; N = 78), deep infiltrating endometriosis (DIE; N = 88), and ovarian endometriosis (Ovarian EM; N = 29). Within each group, patients were categorized according to menstrual cycle phase (menstruation, proliferative, secretory) and hormonal medication at the time of sample collection. Statistical analysis was performed using the Kruskal–Wallis test. p < 0.05 (*), p < 0.001 (***), p < 0.0001 (****).CC BY · PubMed Central
Figure 3 Representative immunofluorescence images demonstrating the colocalization of histamine receptors with nerve fibers or CD45-positive immune cells within endometriotic tissue. (A) Double immunostaining for HRH3 (green) and the neuronal marker PGP9.5 (red) showing HRH3-positive nerve fibers adjacent to a peritoneal endometriosis lesion. (B) HRH3-positive and -negative nerves located proximally and distally to the peritoneal lesion. (C) Double immunostaining for HRH1 (green) and the immune cell marker CD45 (red, marked by the arrows). Squares are marking the nerve fibers. Green squares and arrows indicate positive colocalization, while red squares and arrows indicate negative colocalization. Nuclei are counterstained with DAPI (blue). Images were acquired using a 20× objective. Scale bar: 50 µm for all panels.
Figure 3 Representative immunofluorescence images demonstrating the colocalization of histamine receptors with nerve fibers or CD45-positive immune cells within endometriotic tissue. (A) Double immunostaining for HRH3 (green) and the neuronal marker PGP9.5 (red) showing HRH3-positive nerve fibers adjacent to a peritoneal endometriosis lesion. (B) HRH3-positive and -negative nerves located proximally and distally to the peritoneal lesion. (C) Double immunostaining for HRH1 (green) and the immune cell marker CD45 (red, marked by the arrows). Squares are marking the nerve fibers. Green squares and arrows indicate positive colocalization, while red squares and arrows indicate negative colocalization. Nuclei are counterstained with DAPI (blue). Images were acquired using a 20× objective. Scale bar: 50 µm for all panels.CC BY · PubMed Central
Figure 4 Expression and colocalization of histamine receptors (HRH1–HRH4) with the immune cell marker CD45 in different endometriosis subtypes. Box plots represent the area ratio (%) of HRH1–HRH4, CD45, and their colocalization (HRH + CD45) in control tissues (blue) compared with (A–D) peritoneal endometriosis (pEM), (E–H) deep infiltrating endometriosis (DIE), and (I–L) ovarian endometriosis (oEM). Quantification was performed based on immunofluorescence double staining for each receptor and CD45. The area ratio (%) reflects the proportion of marker-positive area in relation to the overall DAPI-positive area. Statistical analysis was carried out using the Mann–Whitney U test. p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****).
Figure 4 Expression and colocalization of histamine receptors (HRH1–HRH4) with the immune cell marker CD45 in different endometriosis subtypes. Box plots represent the area ratio (%) of HRH1–HRH4, CD45, and their colocalization (HRH + CD45) in control tissues (blue) compared with (A–D) peritoneal endometriosis (pEM), (E–H) deep infiltrating endometriosis (DIE), and (I–L) ovarian endometriosis (oEM). Quantification was performed based on immunofluorescence double staining for each receptor and CD45. The area ratio (%) reflects the proportion of marker-positive area in relation to the overall DAPI-positive area. Statistical analysis was carried out using the Mann–Whitney U test. p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****).CC BY · PubMed Central
Figure 5 Histamine levels in peritoneal fluid (A) and blood serum (B) from control individuals and endometriosis patients. Values are normalized to protein levels (ng/mg protein). Sample sizes were n = 10 for controls and n = 30 for endometriosis patients in peritoneal fluid, and n = 10 for controls and n = 30 for endometriosis patients in serum. Statistical analysis was performed using the non-parametric Mann–Whitney U test (two-tailed); p < 0.01 (**).
Figure 5 Histamine levels in peritoneal fluid (A) and blood serum (B) from control individuals and endometriosis patients. Values are normalized to protein levels (ng/mg protein). Sample sizes were n = 10 for controls and n = 30 for endometriosis patients in peritoneal fluid, and n = 10 for controls and n = 30 for endometriosis patients in serum. Statistical analysis was performed using the non-parametric Mann–Whitney U test (two-tailed); p < 0.01 (**).CC BY · PubMed Central
Figure 6 Methylhistamine levels in urine samples from control individuals and endometriosis patients. Values are normalized to creatinine and expressed in µg/g creatinine. Statistical analysis was performed using the non-parametric Mann–Whitney U test (two-tailed); no significant differences were observed.
Figure 6 Methylhistamine levels in urine samples from control individuals and endometriosis patients. Values are normalized to creatinine and expressed in µg/g creatinine. Statistical analysis was performed using the non-parametric Mann–Whitney U test (two-tailed); no significant differences were observed.CC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 0 Not valid · 26 Not checked · 91 Own results and interpretations

57 more claims

Create a free account to see all 119 claims and to verify the 51 references still open.

See all claims — free account
  • Probably not a substantial claim. 23
  • It may state two separate claims as one. 45

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 53 references

Cited by

See all 8

Metadata

Authors
Velho, R. V., Freitag, J. H., Brueckner, A. M., Thalmeier, L., Pohl, J., & Mechsner, S.
Affiliations
  • Stiftung Charité (DE)
  • Charité – Universitätsmedizin Berlin (DE)
Corresponding author
Mechsner, Sylvia
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2025-12-24
Volume
27
Issue
1
Pages
212
ISSN
1422-0067 (ISSN-L)
OpenAlex
W7117133207
Cited by
7
References
53
Citations by year
2026: 7
FWCI
6.14
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Keywords
endometriosis, histamine, histamine receptors, histidine decarboxylase, methylhistamine, deep infiltrating endometriosis, endometrioma, peritoneal endometriosis, neurogenic inflammation, neuropathic pain, cytokines, interleukin-6, cyclooxygenase-2, nerve growth factor, NGF receptor, endometriosis-associated pain
MeSH terms
Receptors, Histamine H4, Adult, Ascitic Fluid, Endometriosis, Female, Histamine, Histidine Decarboxylase, Humans, Inflammation, Methylhistamines, Receptors, Histamine, Receptors, Histamine H1, Cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Histamine-Associated Inflammatory Landscape of Endometriosis: Molecular Profiling of HDC, HRH1-HRH4, and Cytokines Across Lesion Subtypes. https://app.cochat.ai/papers/10.3390/ijms27010212
The paper
Velho, R. V., Freitag, J. H., Brueckner, A. M., Thalmeier, L., Pohl, J., & Mechsner, S. (2025). The Histamine-Associated Inflammatory Landscape of Endometriosis: Molecular Profiling of HDC, HRH1-HRH4, and Cytokines Across Lesion Subtypes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010212

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.